TRIHEXYPHENIDYL HYDROCHLORIDE tablet

Country: Amerika Syarikat

Bahasa: Inggeris

Sumber: NLM (National Library of Medicine)

Bahan aktif:

TRIHEXYPHENIDYL HYDROCHLORIDE (UNII: AO61G82577) (TRIHEXYPHENIDYL - UNII:6RC5V8B7PO)

Boleh didapati daripada:

REMEDYREPACK INC.

Laluan pentadbiran:

ORAL

Jenis preskripsi:

PRESCRIPTION DRUG

Tanda-tanda terapeutik:

This drug is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.

Ringkasan produk:

Trihexyphenidyl Hydrochloride Tablets, USP 2 mg are 10/32", scored, round, white, flat faced, tablets imprinted DAN DAN and 5335 supplied in NDC: 70518-1612-00 NDC: 70518-1612-01 NDC: 70518-1612-02 PACKAGING: 30 in 1 BLISTER PACK PACKAGING: 100 in 1 BOX PACKAGING: 1 in 1 POUCH Dispense in a tight container with child-resistant closure. Store at 20° to 25° (68° to 77°F) [See USP Controlled Room Temperature]. Repackaged and Distributed By: Remedy Repack, Inc. 625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

Status kebenaran:

Abbreviated New Drug Application

Ciri produk

TRIHEXYPHENIDYL HYDROCHLORIDE- TRIHEXYPHENIDYL HYDROCHLORIDE TABLET
REMEDYREPACK INC.
----------
TRIHEXYPHENIDYL HYDROCHLORIDE TABLETS, USP
RX ONLY
DESCRIPTION
Trihexyphenidyl hydrochloride is a synthetic antispasmodic drug
available in the following forms: Tablets, 2
mg and 5 mg. It is designated chemically
1-Piperidinepropanol,α-cyclohexyl-α-phenyl-, hydrochloride. The
structural formula is represented below:
C
H
NO•HCl M.W. 337.93
Trihexyphenidyl Hydrochloride Tablets USP 2 mg and 5 mg contain the
following inactive ingredients: colloidal
silicon dioxide, dibasic calcium phosphate, lactose monohydrate,
magnesium stearate, microcrystalline
cellulose and sodium starch glycolate.
CLINICAL PHARMACOLOGY
Trihexyphenidyl HCl is the substituted piperidine salt,
3-(1-piperidyl)-1-phenylcyclohexyl-1-propanol
hydrochloride, which exerts a direct inhibitory effect upon the
parasympathetic nervous system. It also has a
relaxing effect on smooth musculature; exerted both directly upon the
muscle tissue itself and indirectly
through an inhibitory effect upon the parasympathetic nervous system.
Its therapeutic properties are similar to
those of atropine, although undesirable side effects are ordinarily
less frequent and severe than with the latter.
INDICATIONS
This drug is indicated as an adjunct in the treatment of all forms of
parkinsonism (postencephalitic,
arteriosclerotic, and idiopathic). It is often useful as adjuvant
therapy when treating these forms of
parkinsonism with levodopa. Additionally, it is indicated for the
control of extrapyramidal disorders caused by
central nervous system drugs such as the dibenzoxazepines,
phenothiazines, thioxanthenes, and
butyrophenones.
WARNINGS
Patients to be treated with trihexyphenidyl HCl should have a
gonioscope evaluation and close monitoring of
intraocular pressures at regular periodic intervals.
PRECAUTIONS
Although trihexyphenidyl HCl is _not_ contraindicated for patients
with cardiac, liver, or kidney disorders, or with
hypertension, such patients should be maintained u